Johns Hopkins Hospital Cancer Registry

Slides:

Advertisements

Similar presentations

Pre-operative Imatinib for metastatic, recurrent and locally advanced GISTs E. Efthimiou, S Mudan E. Efthimiou, S Mudan On behalf of the Sarcoma Group.

Advertisements

Radiologic Imaging Defines the local extent of a tumor Can be used to stage malignant disease Aids in the diagnosis Monitoring tumor changes after treatment.

Treatment of Relapsed Osteosarcoma After Contemporary Therapy: The Memorial Sloan-Kettering Experience Chou AJ, Merola PR, Vyas Y, Wexler L, Gorlick R,

A blanket protocol to study oral regorafenib in patients with refractory liposarcoma, osteogenic sarcoma, and Ewing/Ewing-like sarcoma Coordinating Investigator:

Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.

FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.

SPINDLE CELL SARCOMA OF BONE AN ASSESSMENT OF OUTCOME

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.

PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.

MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

An Assessment of Factors Affecting Outcome in Patients Presenting with Metastatic Soft Tissue Sarcoma Peter Ferguson MD1,2, Benjamin Deheshi MD1,2, Anthony.

LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.

PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009.

HCI Sarcoma Services Sequential Dependency of Radiotherapy for Soft-Tissue Sarcoma S Sampath TE Schultheiss YJ Hitchcock RL Randall DC Shrieve JYC Wong.

Clinical variables, pathological factors, and molecular markers for enhanced soft tissue sarcoma prognostication G. Lahat, B. Wang, D. Tuvin, DA. Anaya,

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

Per-Ulf Tunn, D. Andreou, S. Fehlberg, M. Werner, P. Reichardt

Jens Jakob 1 ; Anna Simeonova 2 ; Bernd Kasper 3 ; Ulrich Ronellenfitsch 1 ; Frederik Wenz 2 ; Peter Hohenberger 1 1 Department of Surgery, 2 Department.

1 Sarcoma Ages >= ** Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at.

Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.

Treatment Patterns in the Management of Prostate Cancer: Lessons Learned from the Florida Cancer Data System Vonetta L. Williams, PhD, MPH, CTR June 23,

GASTRIC CANCER JHH Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or.

ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.

The Burden of Cancer in Connecticut Lou Gonsalves Connecticut Tumor Registry

HEAD/NECK CARCINOMA Johns Hopkins Hospital.

S ARCOMA Diana Marroquin Period 1. W HAT IS SARCOMA ? A type of cancer that develops from certain tissues, like bone or muscle that can spread by extension.

National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.

Johns Hopkins Hospital Cancer Registry Melanoma

JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.

University of Pennsylvania Department of Orthopaedic Surgery Joseph King, Eileen Crawford, Abass Alavi, Arthur Staddon, Lee Hartner, Richard Lackman and.

The Role of the HCC Cancer Registry in Facilitating Cancer Research Linda Cope, CTR HCC Registry Coordinator

Scottish Renal Cancer Forum National Meeting 31st March 2016 Renal cancer survival Period of diagnosis: Roger Black.

ACOSOG Sarcoma Committee Chair: Peter W.T. Pisters, MD Vice Chairs: Edward Cheng, MD (Orthopedic Oncology) Robert Maki, MD, PhD (Medical Oncology) Brian.

Prognostic impact of Ki-67 in Croatian women with early breast cancer (single-institution prospective observational study) Ivan Bilić, Natalija Dedić Plavetić,

Challenges of Rare Cancers…

NON-SMALL CELL LUNG CANCER

Age and Racial/Ethnic Disparities in the Diagnosis of Breast Cancer in an Urban Population Joanne K. Fagan PhD, Denise Fyffe, PhD, Nadine Jenkins, CTR,

Results of Definitive Radiotherapy in Anal Canal Carcinoma

Ovarian Cancer (C56): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation provided.

JOHNS HOPKINS HOSPITAL CANCER REGISTRY

Presented By Deborah Schrag at 2016 ASCO Annual Meeting

Johns Hopkins Hospital Malignant and Benign Brain/CNS

Cancer of the Body of the Uterus (C54):

JOHNS HOPKINS CANCER REGISTRY 2009

ANALYTIC PANCREATIC CANCER by CLASS N = 369

Discordance of histo-pathological diagnosis of patients with soft tissue sarcoma referred to tertiary care center. Rastogi,S., Aggarwal, A., Soti, K.,

Picture 3. Higher grade tumors are more frequently Ki67 positive

Testicular Cancer (C62):

Cervical Cancer (C53): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation.

Supplementary Table 1. (A) S100β Validation set (n=76 ER-positive and ER-negative patients). (B) S100β Validation set (n=59 ER-positive patients). Association.

Breast Cancer (C50): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation provided.

Bowel Cancer (C18-C20): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation.

The Scandinavian Sarcoma Group 25 Years´Jubilee Meeting St

Non-GIST Soft Tissue Sarcoma: Biology and Basics of Targeted Therapy

Apollo Gleneagles Hospitals,

The IASLC Lung Cancer Database

What’s New for 8th Edition

Dr T P E Wells 13 July 2018 Breast SSG Bath

ACOSOG Clinical Trials

Figure 1 Differences in bladder cancer between genders

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

The Changing Face of Cancer in Iowa

4155 primary hepatocellular carcinoma with known diagnosis month/year

Heart Disease, Stroke, Cancer, & AIDS

Published online September 20, 2017 by JAMA Surgery

National Cancer Statistics in Korea, 2015

Soft Tissue Sarcoma: Relative Survival (%), Adults Aged , UK 1-Year

Data Analytics course.

RETROPERITONEAL NON-FUNCTIONING PARAGANGLIOMA: A DIFFICULT TUMOR TO DIAGNOSE AND TREAT GENERAL SURGERY DEPARTMENT I HMIMV.

Trends in survival from metastatic lung cancer in California,

Presentation transcript:

Johns Hopkins Hospital Cancer Registry Sarcoma 2003-2007

JHH Adult Retroperitoneal Soft Tissue Sarcoma 2003-2007, Analytic vs JHH Adult Retroperitoneal Soft Tissue Sarcoma 2003-2007, Analytic vs. Non-Analytic n = 51 (age>18) ** Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at JHH ***Non-Analytic - Initially diagnosed & treated elsewhere to JHH for treatment of recurrent, metastatic or progression of disease

JHH Adult Retroperitoneal Soft Tissue Sarcoma 2003-2007 by Year and Gender, All Cases n = 51

JHH Adult Retroperitoneal Soft Tissue Sarcoma 2003-2007 by Age at Diagnosis, All Cases n = 51

JHH Adult Retroperitoneal Soft Tissue Sarcoma 2003-2007 by Histology, All Cases n = 51

JHH Adult Retroperitoneal Soft Tissue Sarcoma 2003-2007 Grade at Diagnosis, Analytic Cases* n = 38 Low Grade = Grades 1 and 2, High Grade = Grades 3 and 4 * Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at JHH

JHH Adult Retroperitoneal Soft Tissue Sarcoma 2003-2007 Stage at Diagnosis, Analytic Cases Class 1&2 n = 38

Adult Sarcoma Extremities

JHH Adult Soft Tissue Sarcoma of the Extremities 2003-2007, Analytic vs. Non-Analytic n = 124 ** Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at JHH ***Non-Analytic - Initially diagnosed & treated elsewhere to JHH for treatment of recurrent, metastatic or progression of disease

JHH Adult Soft Tissue Sarcoma of the Extremities 2003-2007 by Year and Gender, All Cases n = 124

JHH Adult Soft Tissue Sarcoma Extremities 2003-2007 by Age at Diagnosis, All Cases n = 124

JHH Adult Soft Tissue Sarcoma Extremities 2003-2007 by Histology, All Cases n = 124

JHH Adult Soft Tissue Sarcoma Extremities 2003-2007 Grade at Diagnosis, Analytic Cases n = 112 Low Grade = Grades 1 and 2, High Grade = Grades 3 and 4

JHH Adult Soft Tissue Sarcoma Extremities 2003-2007 Stage at Diagnosis, Analytic Cases n = 112

GIST 2006-2007

JHH GIST 2006-2007, Analytic vs. Non-Analytic n = 41 ** Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at JHH ***Non-Analytic - Initially diagnosed & treated elsewhere to JHH for treatment of recurrent, metastatic or progression of disease

JHH GIST 2006-2007 by Year and Gender, all Cases n = 41

JHH GIST 2006-2007 by Age at Diagnosis, all Cases n = 67

JHH GIST 2006-2007 Site, Analytic Cases n = 41

JHH GIST 2006-2007 by State, All Cases n = 41 JHH Adult Retroperitoneal Soft Tissue Sarcoma 2003-2007 by State, All Cases n = 51 JHH Adult Soft Tissue Sarcoma Extremities 2003-2007 by State, All Cases n = 124 *All Other include: FL, GA, PR, other foreign Other states include: DC, KY, NY, SC, TX JHH GIST 2006-2007 by State, All Cases n = 41

JHH Adult Retroperitoneal Soft Tissue Sarcoma 2003-2007 by Race, All Cases n = 51 JHH Adult Soft Tissue Sarcoma Extremities 2003-2007 by Race, All Cases n = 124

JHH GIST 2006-2007 Treatment, Analytic Cases n = 36 JHH Adult Retroperitoneal Soft Tissue Sarcoma 2003-2007 by Treatment, Analytic Cases, Stages I-IV Class 1&2, n = 35 JHH Adult Soft Tissue Sarcoma Extremities 2003-2007 by Treatment, Analytic Cases Stages I-IV n = 86 JHH GIST 2006-2007 Treatment, Analytic Cases n = 36 *All Other include: RT/Chemo, RT/Surg, Hormone/Surg

JHH Adult Retroperitoneal Sarcoma Relative Survival by AJCC Stage 1995-2004 (n=50)

JHH Adult Soft Tissue Sarcoma Extremities Relative Survival by AJCC Stage 1995-2004 (n=181)